These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


426 related items for PubMed ID: 16607632

  • 1. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E, Palangio M, Gonzalez J, Adler KR, Scarborough R, Goldberg SL, Rowley SD.
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [Abstract] [Full Text] [Related]

  • 2. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N, Donato M, Körbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P.
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [Abstract] [Full Text] [Related]

  • 3. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O, Arat M, Arslan O, Ayyildiz E, Sanli H, Beksac M, Ozcan M, Gürman G, Akan H.
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [Abstract] [Full Text] [Related]

  • 4. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
    Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffler K, Miller KB.
    Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
    [Abstract] [Full Text] [Related]

  • 5. Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E, Palangio M, Gonzalez J, Adler KR, Rowley SD, Goldberg SL.
    Bone Marrow Transplant; 2003 Feb; 31(4):291-4. PubMed ID: 12621465
    [Abstract] [Full Text] [Related]

  • 6. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K, Horwitz ME, Kwatemaa A, Nomicos E, Castro K, Sokolic R, Foster SF, Garofalo M, Choi U, Ryherd M, Brown MR, Leitman SF, Wayne AS, Fowler DH, Bishop MR, Childs RW, Barrett AJ, Pavletic SZ, Malech HL.
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [Abstract] [Full Text] [Related]

  • 7. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ, Ratnavel R, Watkins P, Samson D, Apperley J, Ball J, Taylor P, Russell-Jones R.
    Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
    [Abstract] [Full Text] [Related]

  • 8. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J, Merlin E, Halle P, Paillard C, Marabelle A, Rapatel C, Evrard B, Berger C, Stephan JL, Galambrun C, Piguet C, D'Incan M, Bordigoni P, Deméocq F.
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
    Perseghin P, Galimberti S, Balduzzi A, Bonanomi S, Baldini V, Rovelli A, Dassi M, Rambaldi A, Castagna L, Corti P, Pogliani EM, Uderzo C.
    Ther Apher Dial; 2007 Apr; 11(2):85-93. PubMed ID: 17381528
    [Abstract] [Full Text] [Related]

  • 10. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
    Rubegni P, Cuccia A, Sbano P, Cevenini G, Carcagnì MR, D'Ascenzo G, De Aloe G, Guidi S, Guglielmelli P, Marotta G, Lauria F, Bosi A, Fimiani M.
    Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
    [Abstract] [Full Text] [Related]

  • 11. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
    Bisaccia E, Palangio M, Gonzalez J.
    Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
    [Abstract] [Full Text] [Related]

  • 12. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
    Ayyildiz E, Arslan O, Topçuoğlu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O.
    Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
    [Abstract] [Full Text] [Related]

  • 13. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Bykova TA, Kozlov AV, Stancheva NV, Semënova EV, Kulagina II, Bondarenko SN, Vavilov VN, Morozova EV, Zubarovskaia LS, Afanas'ev BV.
    Ter Arkh; 2013 Feb; 85(8):60-8. PubMed ID: 24137966
    [Abstract] [Full Text] [Related]

  • 14. The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
    Greinix HT, Knobler RM, Worel N, Schneider B, Schneeberger A, Hoecker P, Mitterbauer M, Rabitsch W, Schulenburg A, Kalhs P.
    Haematologica; 2006 Mar; 91(3):405-8. PubMed ID: 16531267
    [Abstract] [Full Text] [Related]

  • 15. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.
    Greinix HT, van Besien K, Elmaagacli AH, Hillen U, Grigg A, Knobler R, Parenti D, Reddy V, Theunissen K, Michallet M, Flowers ME, UVADEX Chronic GVHD Study Group.
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1775-82. PubMed ID: 21621629
    [Abstract] [Full Text] [Related]

  • 16. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D, Hosing C, Saliba R, Shpall EJ, Andelini P, Popat U, Donato M, Champlin R.
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [Abstract] [Full Text] [Related]

  • 17. The effect of extracorporeal photopheresis on intracellular cytokine expression in chronic cutaneous graft-versus-host disease.
    Darvay A, Salooja N, Russell-Jones R.
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):279-84. PubMed ID: 15096136
    [Abstract] [Full Text] [Related]

  • 18. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M, Pessolano R, Albiani R, Asaftei S, Barat V, Carraro F, Biasin E, Madon E, Fagioli F.
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [Abstract] [Full Text] [Related]

  • 19. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2006 Oct; 6(6):1-82. PubMed ID: 23074497
    [Abstract] [Full Text] [Related]

  • 20. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P, Feci L, Poggiali S, Marotta G, D'Ascenzo G, Murdaca F, Fimiani M.
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.